Abstract
The wide use of organophosphorus compounds in industry and home is a certain danger for humans. In this connection the further improvement of the methods to treat organophosphorus poisoning is a significant medical problem. Among many drugs assigned for treatment of organophosphorus intoxication, an important place belongs to muscarinic antagonists (M-antagonists). At the same time, it is necessary to take account of the specific type of muscarinic receptor to be targeted by muscarinic antagonists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dolgo-Saburov V.B., Shorokhov U.A. (1989) Molecular mechanism of cholinoreceptor functioning. Moscow.
Kosmachev A.B., Janchotova M.B., Kosmacheva I.M. (1992) Experim. clin. Pharmacol. 4, 56–58.
Prosorovsky V.B., Prosorovskaja M.P., Demchenko V.M. (1978) Pharmacol. toxicol. 4, 497.
Crossland L., Slater P. (1968) Brit. J. Pharmacol. 33, 42–47.
Yamamura H.I., Snyder H.S. (1974) Proc.Nat.Acad.Soc. USA. 71, 1725–1729.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kosmachev, A.B., Philko, O.A. (1999). Selectivity and Protective Activity of Muscarinic Receptor’s Antagonists in Organophosphates Poisoning. In: Sohns, T., et al. NBC Risks Current Capabilities and Future Perspectives for Protection. NATO Science Series, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4641-8_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-4641-8_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-5803-9
Online ISBN: 978-94-011-4641-8
eBook Packages: Springer Book Archive